Company Profiles

driven by the PitchBook Platform

Autifony Therapeutics

Description

Developer of medicines for the treatment of hearing disorders. The company is focused on the identification and development of novel pharmaceuticals to treat hearing loss, tinnitus and other serious disorders of the central nervous system.

2011

Founded

PRIVATE

Status

1-10

Employees

Series A3

Latest Deal Type

$12.4M

Latest Deal Amount

$38.9M

Total Amount Raised

Description

Developer of medicines for the treatment of hearing disorders. The company is focused on the identification and development of novel pharmaceuticals to treat hearing loss, tinnitus and other serious disorders of the central nervous system.

Website:

www.autifony.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

Imperial College Incubator Level 1 Bessemer Building, Imperial College London London SW7 2AZEngland
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Autifony Therapeutics's full profile, request a free trial.

Autifony Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Autifony Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Autifony Therapeutics Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
GlaxoSmithKlineCorporationMinority000 0000000 0000
International Biotechnology TrustOtherMinority000 0000000 0000
Pfizer Venture InvestmentsCorporate Venture CapitalMinority000 0000000 0000
SV Health InvestorsVenture CapitalMinority000 0000000 0000
Technology Strategy Board of UKGovernment000 0000000 0000
GlaxoSmithKline Corporation
International Biotechnology Trust Other
Pfizer Venture Investments Corporate Venture Capital
SV Health Investors Venture Capital
Technology Strategy Board of UK Government

Autifony Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Charles Large Ph.DCo-Founder, Board Member & Chief Executive Officer
Chi FokChief Financial Officer and Executive Director
Barbara Domayne-HaymanChief Business Officer
Giuseppe Alvaro Ph.DCo-Founder & Head of Drug Discovery
John Hutchison Ph.DChief Medical Officer
Charles Large Ph.D Co-Founder, Board Member & Chief Executive Officer
Chi Fok Chief Financial Officer and Executive Director
Barbara Domayne-Hayman Chief Business Officer
Giuseppe Alvaro Ph.D Co-Founder & Head of Drug Discovery
John Hutchison Ph.D Chief Medical Officer

Autifony Therapeutics Board Members (8)

NameRepresentingRoleSinceContact
Info
Allan Baxter Ph.DSelfBoard Member000 0000
Atul Pande MDSelfBoard Member000 0000
Catherine BinghamSV Health InvestorsManaging Partner, Biotechnology000 0000
Charles Large Ph.DAutifony TherapeuticsCo-Founder, Board Member & Chief Executive Officer000 0000
Elaine Jones Ph.DPfizer Venture InvestmentsExecutive Director000 0000
Allan Baxter Ph.D Board Member Self
Atul Pande MD Board Member Self
Catherine Bingham Managing Partner, Biotechnology SV Health Investors
Charles Large Ph.D Co-Founder, Board Member & Chief Executive Officer Autifony Therapeutics
Elaine Jones Ph.D Executive Director Pfizer Venture Investments
Request full access to PitchBook